Bahto Biosciences
Bahto Biosciences develops non-opioid small-molecule therapeutics for painful peripheral neuropathy, a condition with limited effective treatment options that afflicts more than 19 million Americans.
Why it ranks
How the rank works- went through Plug and PlayProgram · this site+1
A sum of public facts, not a judgement and not investment advice.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Encepheal TherapeuticsShared: molecule therapeutic, small molecule, opioidYC S19InactiveOther | Other | Inactive | YCS19 |
| Other | Not stated | MassChallengeSwitzerland 2025 | |
| Other | Active | YCW21 | |
| Other | Not stated | Plug and Play | |
| Other | Not stated | Seedcamp2019 |
Adjacent
Also from Plug and Play
All of Plug and PlayPrograms
| Program | Cohort | Source |
|---|---|---|
| Not stated | Plug and Play Page |
About Bahto Biosciences
Bahto Biosciences is a health and lifetech company focused on developing non-opioid small-molecule therapeutics for painful peripheral neuropathy, a condition with limited effective treatment options. The company utilizes a proprietary chemical scaffold to generate novel composition-of-matter derivatives that have demonstrated in vivo efficacy. Bahto Biosciences aims to advance its lead candidate toward investigational new drug-enabling studies, potentially delivering the first disease-modifying therapy for this challenging condition. Founded by experienced drug discovery experts with a strong track record in advancing multiple drugs to clinical trials and successful asset development, Bahto Biosciences contributes to innovation by addressing unmet medical needs through pioneering therapeutic approaches.
- Category
- Other
- Location
- United States
- Checked
- 7h ago
Bahto Biosciences: questions
Which accelerators did Bahto Biosciences go through?
Bahto Biosciences is listed by Plug and Play.
Where is Bahto Biosciences based?
Bahto Biosciences lists United States as its location on Plug and Play's page.